» Articles » PMID: 12167566

Glucuronidation of Dihydroartemisinin in Vivo and by Human Liver Microsomes and Expressed UDP-glucuronosyltransferases

Overview
Specialty Pharmacology
Date 2002 Aug 9
PMID 12167566
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to elucidate the metabolic pathways for dihydroartemisinin (DHA), the active metabolite of the artemisinin derivative artesunate (ARTS). Urine was collected from 17 Vietnamese adults with falciparum malaria who had received 120 mg of ARTS i.v., and metabolites were analyzed by high-performance liquid chromatography-mass spectrometry (HPLC-MS). Human liver microsomes were incubated with [12-(3)H]DHA and cofactors for either glucuronidation or cytochrome P450-catalyzed oxidation. Human liver cytosol was incubated with cofactor for sulfation. Metabolites were detected by HPLC-MS and/or HPLC with radiochemical detection. Metabolism of DHA by recombinant human UDP-glucuronosyltransferases (UGTs) was studied. HPLC-MS analysis of urine identified alpha-DHA-beta-glucuronide (alpha-DHA-G) and a product characterized as the tetrahydrofuran isomer of alpha-DHA-G. DHA was present only in very small amounts. The ratio of the tetrahydrofuran isomer, alpha-DHA-G, was highly variable (median 0.75; range 0.09-64). Nevertheless, alpha-DHA-G was generally the major urinary product of DHA glucuronidation in patients. The tetrahydrofuran isomer appeared to be at least partly a product of nonenzymic reactions occurring in urine and was readily formed from alpha-DHA-G by iron-mediated isomerization. In human liver microsomal incubations, DHA-G (diastereomer unspecified) was the only metabolite found (V(max) 177 +/- 47 pmol min(-1) mg(-1), K(m) 90 +/- 16 microM). Alpha-DHA-G was formed in incubations of DHA with expressed UGT1A9 (K(m) 32 microM, V(max) 8.9 pmol min(-1) mg(-1)) or UGT2B7 (K(m) 438 microM, V(max) 10.9 pmol mg(-1) min(-1)) but not with UGT1A1 or UGT1A6. There was no significant metabolism of DHA by cytochrome-P450 oxidation or by cytosolic sulfotransferases. We conclude that alpha-DHA-G is an important metabolite of DHA in humans and that its formation is catalyzed by UGT1A9 and UGT2B7.

Citing Articles

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers.

Tarning J, Hanboonkunupakarn B, Hoglund R, Chotivanich K, Mukaka M, Pukrittayakamee S Malar J. 2024; 23(1):296.

PMID: 39363296 PMC: 11450984. DOI: 10.1186/s12936-024-05085-9.


Dihydroartemisinin ameliorates cerebral I/R injury in rats via regulating VWF and autophagy-mediated SIRT1/FOXO1 pathway.

Duan Q, Wu J Open Med (Wars). 2023; 18(1):20230698.

PMID: 37415610 PMC: 10320570. DOI: 10.1515/med-2023-0698.


Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV.

Banda C, Nkosi D, Allen E, Workman L, Madanitsa M, Chirwa M Antimicrob Agents Chemother. 2022; 66(12):e0058422.

PMID: 36374096 PMC: 9764988. DOI: 10.1128/aac.00584-22.


The Impact of Extended Treatment With Artemether-lumefantrine on Antimalarial Exposure and Reinfection Risks in Ugandan Children With Uncomplicated Malaria: A Randomized Controlled Trial.

Whalen M, Kajubi R, Goodwin J, Orukan F, Colt M, Huang L Clin Infect Dis. 2022; 76(3):443-452.

PMID: 36130191 PMC: 9907485. DOI: 10.1093/cid/ciac783.


Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Infection.

Minzi O, Mnkugwe R, Ngaimisi E, Kinunghi S, Hansson A, Pohanka A Pharmaceuticals (Basel). 2021; 14(5).

PMID: 33922522 PMC: 8145331. DOI: 10.3390/ph14050400.